INO icon

Inovio Pharmaceuticals

212 hedge funds and large institutions have $723M invested in Inovio Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

4% less first-time investments, than exits

New positions opened: 48 | Existing positions closed: 50

53% less capital invested

Capital invested by funds: $1.52B → $723M (-$801M)

Holders
212
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$117M
Puts
$104M
Net Calls
Net Calls Change

Top Buyers

1 +$16.5M
2 +$14.7M
3 +$10.8M
4
Bank of America
Bank of America
North Carolina
+$10.3M
5
Coatue Management
Coatue Management
New York
+$9.59M

Top Sellers

1 -$20.8M
2 -$16M
3 -$13.9M
4
Jane Street
Jane Street
New York
-$5.7M
5
TCM
Tekla Capital Management
Massachusetts
-$5.45M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$3.41M
27
$3.3M
28
$3.28M
29
$2.92M
30
$2.89M
31
$2.78M
32
$2.75M
33
$2.68M
34
$2.59M
35
$2.49M
36
$2.28M
37
$2.26M
38
$2.23M
39
$2.22M
40
$2.21M
41
$1.99M
42
$1.65M
43
$1.53M
44
$1.5M
45
$1.45M
46
$1.39M
47
$1.34M
48
$1.22M
49
$1.21M
50
$1.16M